# Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

> **NCT05229237** · — · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 500 (actual)

## Conditions studied

- Polypoidal Choroidal Vasculopathy
- Conbercept

## Interventions

- **DRUG:** Conbercept

## Key facts

- **NCT ID:** NCT05229237
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2021-06-05
- **Final completion:** 2021-12-05
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05229237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05229237, "Conbercept for Polypoidal Choroidal Vasculopathy（START Study）". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05229237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*